These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21792028)
61. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J; Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860 [TBL] [Abstract][Full Text] [Related]
63. Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma. Bajpai M; Pal K; Agarwala S; Seth T; Gupta AK Pediatr Surg Int; 2005 May; 21(5):364-8. PubMed ID: 15838617 [TBL] [Abstract][Full Text] [Related]
64. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children. Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026 [TBL] [Abstract][Full Text] [Related]
65. Current chemotherapeutic approaches for hepatoblastoma. Watanabe K Int J Clin Oncol; 2013 Dec; 18(6):955-61. PubMed ID: 24052132 [TBL] [Abstract][Full Text] [Related]
66. Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival. Powers JM; Pacheco MM; Wickiser JE J Pediatr Hematol Oncol; 2019 Apr; 41(3):e171-e173. PubMed ID: 29668545 [TBL] [Abstract][Full Text] [Related]
67. Resectability of advanced liver tumours in children after combination chemotherapy. Munro FD; Simpson E; Azmy AF Ann R Coll Surg Engl; 1994 Jul; 76(4):253-6. PubMed ID: 8074387 [TBL] [Abstract][Full Text] [Related]
68. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Katzenstein HM; Furman WL; Malogolowkin MH; Krailo MD; McCarville MB; Towbin AJ; Tiao GM; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Rodriguez-Galindo C; Meyers RL Cancer; 2017 Jun; 123(12):2360-2367. PubMed ID: 28211941 [TBL] [Abstract][Full Text] [Related]
69. New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years. Tannuri AC; Cristofani LM; Teixeira RA; Odone Filho V; Tannuri U Clinics (Sao Paulo); 2015 Jun; 70(6):387-92. PubMed ID: 26106955 [TBL] [Abstract][Full Text] [Related]
70. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99. Häberle B; Maxwell R; Schweinitz DV; Schmid I Klin Padiatr; 2019 Nov; 231(6):283-290. PubMed ID: 31645068 [TBL] [Abstract][Full Text] [Related]
71. Outcome and complications after resection of hepatoblastoma. Towu E; Kiely E; Pierro A; Spitz L J Pediatr Surg; 2004 Feb; 39(2):199-202; discussion 199-202. PubMed ID: 14966740 [TBL] [Abstract][Full Text] [Related]